Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xianfang Meng has a total of 89 co-authors. Here are the top co-authors by number of shared publications:

  • Chun Zhang

    Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

    10 shared publications
  • Chun Zhang

    8 shared publications
  • Yanfang Su

    Department of Neurobiology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    4 shared publications
  • Hua Su

    Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    3 shared publications
  • Kaining Zhi

    Department of Neurobiology, Institute of Brain Research, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    3 shared publications
  • Man Li

    Huazhong University of Science and Technology

    3 shared publications

Latest Publications

  • Open Access

    Loss of minichromosome maintenance 4 leads to early renal dysplasia and cystogenesis outcomes

    by Jing Huang, Hui-Ling Xiang, Qian Yuan, Chun Zhang, Xian-Fang Meng

  • Open Access

    Conditional deletion of MDM2 in neurons impairs neuronal homeostasis and cognitive ability

    by Ying Jin, Hengzhen Cui, Junya Kang, Wenqi Chen, Chuanlin Zhang, Chun Zhang, Yunyun Han, Xianfang Meng

  • NCOA3 as a Key Regulator in Diabetic Cognitive Dysfunction

    by Yanfang Su, Lijing Zhang, Hengzhen Cui, Chun Zhang, Xianfang Meng

    Diabetes-related cognitive dysfunction (DCD) represents a significant complication of diabetes mellitus, yet its underlying molecular mechanisms remain incompletely elucidated. In this study, we aimed to investigate the potential role of nuclear receptor coactivator 3 (NCOA3) in DCD pathogenesis using both conditional knockout (cKO) and lentivirus-mediated overexpression mouse models. Diabetes was induced through combined high-fat diet feeding and low-dose streptozotocin (STZ) administration. Comprehensive behavioral assessments, including novel object recognition test (NORT), Y-maze, and contextual fear conditioning (CFC), were performed alongside molecular analyses of NCOA3/AGO2 expression and downstream targets. Our results suggested a significant downregulation of NCOA3 expression in cortical and hippocampal tissues of diabetic mice. Genetic ablation of NCOA3 in forebrain excitatory neurons markedly appeared to exacerbate hippocampus-dependent cognitive deficits, while targeted hippocampal NCOA3 overexpression effectively ameliorated these impairments. At the mechanistic level, NCOA3 deficiency was associated with reduced protein levels of AGO2, along with downregulation of the synaptic markers synaptophysin (SYP) and postsynaptic density protein 95 (PSD-95). In vitro studies using primary neuronal cultures indicated that high glucose treatment similarly reduced the expression of both NCOA3 and AGO2, while pharmacological inhibition or genetic knockdown of NCOA3 was found to significantly upregulate miR-138-5p levels. These findings collectively suggested a potential regulatory axis wherein NCOA3 is associated with synaptic plasticity via AGO2/miR-138-5p signaling, providing insights into DCD pathogenesis.


  • Open Access

    Interplay between the Redox System and Renal Tubular Transport

    by Xiao-Lan Wang, Lianjian Li, Xianfang Meng

    The kidney plays a critical role in maintaining the homeostasis of body fluid by filtration of metabolic wastes and reabsorption of nutrients. Due to the overload, a vast of energy is required through aerobic metabolism, which inevitably leads to the generation of reactive oxygen species (ROS) in the kidney. Under unstressed conditions, ROS are counteracted by antioxidant systems and maintained at low levels, which are involved in signal transduction and physiological processes. Accumulating evidence indicates that the reduction–oxidation (redox) system interacts with renal tubular transport. Redox imbalance or dysfunction of tubular transport leads to renal disease. Here, we discuss the ROS and antioxidant systems in the kidney and outline the metabolic dysfunction that is a common feature of renal disease. Importantly, we describe the key molecules involved in renal tubular transport and their relationship to the redox system and, finally, summarize the impact of their dysregulation on the pathogenesis and progression of acute and chronic kidney disease.


  • Open Access

    Targeting MAD2B as a strategy for ischemic stroke therapy

    by Lijing Zhang, Hengzhen Cui, Wandi Hu, Xianfang Meng, Chun Zhang


  • Effect of eIF2α in Neuronal Injury Induced by High Glucose and the Protective Mechanism of Resveratrol

    by Lijing Zhang, Kaining Zhi, Yanfang Su, Wenpeng Peng, Xianfang Meng

    Diabetes mellitus (DM) is a type of metabolic disease characterized by chronic hyperglycemia, which can lead to different degrees of cognitive decline. Therefore, it is crucial to explore the molecular biological mechanisms of neuronal injury. In this study, we investigated the effect of high glucose on eIF2α expression and the mechanism of neuronal injury, and on this basis, the protective mechanism of resveratrol is explored. Treatment with 50 mM high glucose in cortical neurons increased the levels of eIF2α phosphorylation; the expressions of ATF4 and CHOP increased. ISRIB alleviated high glucose-induced neuronal injury by reducing eIF2α phosphorylation when neurons were pretreated with ISRIB before high glucose treatment. Compared with the high glucose-treated group, resveratrol pretreatment reduced eIF2α phosphorylation, the levels of its downstream molecules ATF4 and CHOP, and LDH release. Resveratrol reduced the level of cortical eIF2α phosphorylation and the expression of its downstream molecules in DM mice and improved the ability of spatial memory and learning in DM mice without affecting anxiety and motor performance. Meanwhile, resveratrol modulated the expression of Bcl-2 protein and also effectively decreased the DM-induced up-regulation of Bax, caspase-3, p53, p21, and p16. Taken together, these results suggested that high glucose caused neuronal injury through the eIF2α/ATF4/CHOP pathway which was inhibited by ISRIB and resveratrol. The present study indicates that eIF2α is the new target for the treatment of high glucose-induced neuronal injury, and resveratrol is a potential new medicine to treat diabetes encephalopathy.


  • Open Access

    MAD2B Blunts Chronic Unpredictable Stress and Corticosterone Stimulation–Induced Depression-Like Behaviors in Mice

    by Xiao-Lan Wang, Cheng Miao, Yanfang Su, Chun Zhang, Xianfang Meng

    Depression is a prevalent and recurrent psychiatric disorder. Aberrant neural structure and activity play fundamental roles in the occurrence of depression. Mitotic arrest deficient protein (MAD2B) is highly expressed in neurons and may be implicated in synaptic plasticity in the central nervous system. However, the effect of MAD2B in depression, as well as the related molecular mechanism, is uncertain. Here, we employed mouse models of depression induced by chronic unpredictable stress exposure or corticosterone (CORT) stimulation. Depression-like behaviors in mice were evaluated by sucrose preference, forced swimming, and tail suspension tests. Hippocampal MAD2B overexpression was mediated by adeno-associated virus 8 containing enhanced green fluorescent protein. In vitro primary neuronal cells were obtained from the hippocampus of rat embryos and were treated with CORT, and MAD2B overexpression was performed using lentivirus. MAD2B and glutamate metabotropic receptor 4 (GRM4) levels were evaluated by western blots and quantitative PCR. Primary neuronal miR-29b-3p expression was detected by quantitative PCR. MAD2B expression was reduced in the hippocampus in mice exhibiting depressive-like behaviors. However, hippocampal MAD2B overexpression protected mice from developing either chronic unpredictable stress– or CORT-induced depression-like behaviors, an effect associated with reduced expression of GRM4, a presynaptic receptor involved in depression. Moreover, MAD2B overexpression in primary neuronal cells also decreased GRM4 expression while enhancing the level of miR-29b-3p; this phenomenon was also observed under CORT stimulation. Our results suggest an important role of neuronal MAD2B in the pathogenesis of depression via the miR-29b-3p/GRM4 signaling pathway. MAD2B could be a potential therapeutic target for depressive disorders.


  • Open Access

    Conditional deletion of MAD2B in forebrain neurons enhances hippocampus-dependent learning and memory in mice

    by Li Cheng, Yanfang Su, Kaining Zhi, Yaru Xie, Chun Zhang, Xianfang Meng

    Mitotic arrest deficient 2-like protein 2 (MAD2B) is not only a DNA damage repair agent but also a cell cycle regulator that is widely expressed in the hippocampus and the cerebral cortex. However, the functions of MAD2B in hippocampal and cerebral cortical neurons are poorly understood. In this study, we crossed MAD2Bflox/flox and calcium/calmodulin-dependent protein kinase II alpha (Camk2a)-Cre mice to conditionally knock out MAD2B in the forebrain pyramidal neurons by the Cre/loxP recombinase system. First, RNA sequencing suggested that the differentially expressed genes in the hippocampus and the cerebral cortex between the WT and the MAD2B cKO mice were related to learning and memory. Then, the results of behavioral tests, including the Morris water maze test, the novel object recognition test, and the contextual fear conditioning experiment, suggested that the learning and memory abilities of the MAD2B cKO mice had improved. Moreover, conditional knockout of MAD2B increased the number of neurons without affecting the number of glial cells in the hippocampal CA1 and the cerebral cortex. At the same time, the number of doublecortin-positive (DCX+) cells was increased in the dentate gyrus (DG) of the MAD2B cKO mice. In addition, as shown by Golgi staining, the MAD2B cKO mice had more mushroom-like and long-like spines than the WT mice. Transmission electron microscopy (TEM) revealed that spine synapses increased and shaft synapses decreased in the CA1 of the MAD2B cKO mice. Taken together, our findings indicated that MAD2B plays an essential role in regulating learning and memory.


  • Open Access

    Ellagic Acid and Its Anti-Aging Effects on Central Nervous System

    by Heyu Zhu, Yuanmei Yan, Yi Jiang, Xianfang Meng

    Aging is an unavoidable biological process that leads to the decline of human function and the reduction in people’s quality of life. Demand for anti-aging medicines has become very urgent. Many studies have shown that ellagic acid (EA), a phenolic compound widely distributed in dicotyledonous plants, has powerful anti-inflammation and antioxidant properties. Moreover, it has been demonstrated that EA can enhance neuronal viability, reduce neuronal defects, and alleviate damage in neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and cerebral ischemia. This paper reviews the biochemical functions and neuroprotective effects of EA, showing the clinical value of its application.


  • Open Access

    Pathogenic Role of MicroRNA Dysregulation in Podocytopathies

    by Feng Liu, Jiefang Chen, Changqing Luo, Xianfang Meng

    MicroRNAs (miRNAs) participate in the regulation of various important biological processes by regulating the expression of various genes at the post-transcriptional level. Podocytopathies are a series of renal diseases in which direct or indirect damage of podocytes results in proteinuria or nephrotic syndrome. Despite decades of research, the exact pathogenesis of podocytopathies remains incompletely understood and effective therapies are still lacking. An increasing body of evidence has revealed a critical role of miRNAs dysregulation in the onset and progression of podocytopathies. Moreover, several lines of research aimed at improving common podocytopathies diagnostic tools and avoiding invasive kidney biopsies have also identified circulating and urine miRNAs as possible diagnostic and prognostic biomarkers for podocytopathies. The present review mainly aims to provide an updated overview of the recent achievements in research on the potential applicability of miRNAs involved in renal disorders related to podocyte dysfunction by laying particular emphasis on focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), membranous nephropathy (MN), diabetic kidney disease (DKD) and IgA nephropathy (IgAN). Further investigation into these dysregulated miRNAs will not only generate novel insights into the mechanisms of podocytopathies, but also might yield novel strategies for the diagnosis and therapy of this disease.